Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TCF4 antisense RNA 1 (TCF4-AS1) is a long non-coding RNA located on chromosome 18 that is transcribed antisense to the TCF4 gene. It is also known as MIR4529 host gene (MIR4529HG), indicating that it hosts the microRNA MIR4529 sequence within its transcript. As an lncRNA, it is presumed to have roles in regulation of gene expression at the transcriptional or post-transcriptional level, but no specific biological or disease functions, drug interactions, or biomarker roles are documented in current search results. The sequence is well-annotated in gene databases and is not a protein-coding target[3]. If newly requested detail is needed, such as detailed molecular function, disease relevance, or drug interactions, further information should be sourced from specialized lncRNA literature or experimental studies, as none were included in the search results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TCF4 antisense RNA 1 (TCF4-AS1).